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Objectives. Fatigue is common and debilitating among dialysis patients. The aim of this
study was to understand the longitudinal trajectory of fatigue and consider sociodemo-
graphic, clinical, and psychological factors that are related to variation in fatigue levels over
time.
Design. A prospective study of fatigue with yearly assessments over 3 years among
prevalent in-centre haemodialysis (HD) patients.
Methods. Fatigue severity was measured using the Chalder Fatigue Questionnaire and
fatigue-related functional impairment using the Work and Social Adjustment Scale. The
trajectories of fatigue outcomes were examined using piecewise growth models, using
length of time on dialysis as time. Sociodemographic, clinical, and psychological predictors
of fatigue were assessed using linear growth models, using follow-up time.
Results. One hundred and seventy-four prevalent HD patients completed baseline
measures, 118 at 12 months, 84 at 24 months, and 66 at 36 months. Fatigue severity
scores decreased by 0.15 each year. Fatigue-related functional impairment increased by
1.17 each year. In adjusted linear growth models, non-white ethnicity was a significant
predictor of lower initial fatigue severity (B = 2.95, 95% CI 5.51 to 0.40) and a
greater reduction in fatigue severity of 1.60 each year (95% CI 0.35–2.36). A one-point
increase in damage beliefs was associated with a 0.36 increase in fatigue-related functional
impairment each year (95% CI 0.61 to 0.01).
Conclusion. Damage beliefs predicted an increase in fatigue-related functional
impairment over time. However, the data strongly suggested that fatigue outcomes vary
by length of time on dialysis.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and
reproduction in any medium, provided the original work is properly cited.
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Statement of contribution
What is already known on this subject?
 At least 1 in 2 haemodialysis (HD) patients are clinically fatigued.
 Growing evidence is available on the important role of psychological factors in fatigue across
chronic conditions.
 The contribution of psychological factors, beyond distress, to fatigue in HD has not been examined
to date.
What does this study add?
 Ethnicity played a role in the initial level of fatigue severity and over time.
 Damage beliefs predicted an increase in fatigue-related impairment over time.
 Data strongly suggested that fatigue outcomes vary by length of time on dialysis.
In most developed countries of the world, including the United Kingdom and the United
States, the most common renal replacement therapy (RRT) is haemodialysis (HD),
particularly at the start and among patients older than 65 (Hole et al., 2018;MacNeill et al.,
2018). Fatigue is among the most common symptoms experienced by dialysis patients,
affecting at least half, which often interferes with daily life and functioning (Horigan,
2012). Fatigue is a complex and subjective symptom that has been previously described as
a distressing and persistent feeling of physical, emotional, and/or cognitive tiredness not
proportional to exertion and not relieved by rest (Cella et al., 1998; Dittner et al., 2004;
Ream & Richardson, 1996). There is also evidence to suggest that fatigue may contribute
directly and indirectly to adverse clinical outcomes in dialysis patients (Bossola et al.,
2015; Jhamb et al., 2009, 2011; Koyama et al., 2010; Picariello et al., 2018).
The Standardized Outcomes in Nephrology for HD workshop identified fatigue to be a
core outcome (Evangelidis et al., 2017); however, a poor understanding of thepathogenesis
of fatigue in this patient population impedes effective fatigue management strategies.
Current management of fatigue in the form of pharmacological treatments appears
ineffective (Bossola et al., 2011). Exercise-based interventions, although typically effective
(Cheema & Singh, 2005; Segura-Ortı, 2010), have been criticized for being unsuitable for
patients with multimorbidities, disabilities, and in poorer health (Kosmadakis et al., 2010).
Therefore, a solely biomedical approach may be insufficient in this setting. An alternative
model that has been postulated in the literature to explain fatigue across long-term
conditions (LTCs) is the cognitive-behavioural model (Wessely et al., 1998). According to
this model, primary disease factors, such as anaemia, inflammation, and dialysis may trigger
fatigue, yet, how patients react cognitively, emotionally, and behaviourally to the initial
symptom of fatigue may worsen, maintain and perpetuate fatigue over time (Figure 1;
Donovan et al., 2007; vanKessel &Moss-Morris, 2006). For example, once fatigue develops
as a consequence of underlying disease processes, interpretations of fatigue as uncontrol-
lable and lasting, and unhelpful thinking styles in response to fatigue, such as catastrophiz-
ing, symptom focusing, or perceiving fatigue as a sign of bodily damage (damage beliefs),
may lead to increased anxiety and low mood and subsequently unhelpful behavioural
responses, such as excessive rest in an attempt to control fatigue and reduce the damage
perceived it is doing to their body. Excessive rest may in turn lead to deconditioning, poor
sleep and physiological arousal related to anxious mood, and lead to the perpetuation of
fatigue (van Kessel & Moss-Morris, 2006; Van der Werf et al., 2003; Vercoulen et al., 1998;
Wessely et al., 1998). The importance of these factors in maintaining and perpetuating
fatigue has been extensively documented in other conditions, including multiple sclerosis
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(MS), rheumatoid arthritis (RA), andcancer (Ali etal., 2017;Alsen et al., 2010;Grayson etal.,
2013; Jopson &Moss-Morris, 2003; van Kessel &Moss-Morris, 2006; Zalai et al., 2015). This
conceptualization of fatigue has led to psychological treatments associated with clinically
Figure 1. Cognitive-behavioural model of fatigue in chronic illness. This figure illustrates how fatigue can
be triggered by primary disease factors, such as anaemia or haemodialysis in this patient group, and it can
then be perpetuated and maintained by a cycle of negative beliefs, depression and/or anxiety, and
maladaptive behavioural patterns. Over time, this self-perpetuating cycle may also lead to physiological
consequences, such as increased inflammation, disruption of the sleep–wake cycle, chronic activation of
the central and autonomic nervous systems as well as the endocrine system in response to stress, and
deconditioning. This can further maintain fatigue and lead to poorer clinical outcomes.
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significant improvements in fatigue and related outcomes in MS, RA and cancer (Cramp
et al., 2013; Kangas et al., 2008; van den Akker et al., 2016).
Nonetheless, psychological factors remain largely unexplored in fatigue among kidney
failure patients (Picariello et al., 2017b, 2017). According to a recent study that examined
changes in fatigue over 1 year among HD patients, the mean level of fatigue severity was
relatively stable over time, but variations were evident in fatigue status among patients
(Bossola et al., 2017), possibly indicative of distinct fatigue trajectories. These variations in
status were largely unexplained by sociodemographic and clinical factors, except for the
role of comorbidities, but psychological factors were not examined (Bossola et al., 2017).
The cross-sectional data here suggested that dialysis patients’ beliefs, mood, and behaviours
contribute to fatigue, in particular, distress, negative beliefs about fatigue, and unhelpful
behaviours (all-or-nothing and avoidance behaviours) were significant predictors of greater
fatigue severity, explaining an additional 36% of variance (Chilcot et al., 2016). Similarly,
distress, damage beliefs, avoidance behaviours, and fatigue severity were significant
predictors of greater fatigue-related functional impairment, explaining an additional 44% of
variance (Chilcot et al., 2016). In the current paper, the longitudinal findings are presented.
The overarching aim of this study was to understand the longitudinal trajectory of
fatigue in HD patients and consider factors that are related to variation in fatigue levels
over time, with the following objectives:
Primary objectives
1. Tomodel the longitudinal trajectory of fatigue symptoms in dialysis patients over a 3-
year period.
2. To evaluate the contribution of demographic, clinical, cognitive, behavioural, and
emotional factors to fatigue over a 3-year period.
Secondary objective
3. To determine the level and trajectory of functional impairment caused by fatigue over
a 3-year period
Given the paucity of longitudinal fatigue data, an inductive approach to the modelling
of trajectories was adopted. We hypothesized that negative beliefs about fatigue, distress,
unhelpful cognitive and behavioural responses to fatigue will predict greater fatigue
severity and fatigue-related functional impairment over time, after controlling for
sociodemographic and clinical factors.
Methods
Study design
This was a prospective study assessing the trajectories and predictors of fatigue severity
and fatigue-related functional impairment over 36 months. Assessments were conducted
at yearly intervals (baseline, 12, 24, and 36 months). Ethical approval was granted by East
Midlands-Leicester NRES committee (REC Reference number 14/EM/0037). Patient
consent was obtained.
Participants
Patients were recruited from a renal outpatient service in England. All the patients were
receiving thrice-weekly HD, with sessions generally lasting between 3.5 and 5 hr and
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relying on exclusively high flux membranes (polysulphone) with bicarbonate used as a
buffer. The study ran between April 2014 and August 2017. A total of 279 patients were
approached for study participation,with 174providing informed consent and completing
the baseline measures (62.4%). Details of the study including patient recruitment have
previously been reported (Chilcot et al., 2016), and further detail on patient attrition is
available elsewhere (Picariello et al., 2018). In brief, at 12 months 118 patients (87% of
patients still alive, on dialysis, and able to complete the questionnaires) completed
questionnaires, at 24 months 84patients (98%of patients still alive, on dialysis, and able to
complete the questionnaires) completed questionnaires, and at 36 months 66 patients
completed questionnaires (99% of patients still alive, on dialysis, and able to complete the
questionnaires). Although, at 36 months, only 37.9%of the baseline samplewas available,
attrition was driven by mortality and transplantation, with prevalence rates in line with
the renal registry data (Byrne et al., 2018).
The inclusion criteria were as follows: (1) adults with a confirmed kidney failure
diagnosis, (2) aged 18 or older, (3) treated with conventional thrice-weekly in-centre HD,
(4)with a dialysis longevity>90 days, (5) able to speak orwrite in English, and (6) able and
willing to provide informed consent. Patients were excluded if they had significant visual
or physical impairment preventing completion of the questionnaires, had any known
cognitive impairments, and had seriousmental health conditions as noted in theirmedical
history. Patients were not approached if they were judged to be unsuitable by the nursing
staff, such as approaching end of life care, repeatedly unwell during the recruitment
period or in the process of moving to peritoneal dialysis.
Data collection
Participants completed the study measures during a stable dialysis session at least 20 min
after the initiation of treatment. Further detail on the sociodemographic and clinical data
collected at baseline and at each data collection time-point is available elsewhere (Chilcot
et al., 2016). Comorbidity was evaluated using the Charlson Comorbidity Index (CCI) at
baseline (Charlson et al., 1987).
Psychological measures
All psychological measures were administered at each follow-up. The primary outcome
variable, fatigue severity was measured using the Chalder Fatigue Questionnaire (CFQ;
Chalder et al., 1993). This questionnaire has not been developed specifically for HD;
therefore, it captures general fatigue. This scale consists of 11 items and scores are
assigned for each response, using continuous scoring from 0 to 3. Higher scores represent
greater fatigue severity. A cut-off of greater than 18 defines a fatigue case (Chalder et al.,
1993; White et al., 2011). The measure has good psychometric properties in HD patients
(Picariello et al., 2016).
The secondary outcome variable, fatigue-related functional impairment, was mea-
sured using the Work and Social Adjustment Scale (WSAS; Mundt et al., 2002). The
following psychological predictor variables were measured using validated measures:
fatigue perceptions using the Brief Illness Perceptions Questionnaire (BIPQ; Broadbent
et al., 2006), cognitive and behavioural responses to fatigue via the Cognitive and
Behavioural Responses to SymptomsQuestionnaire (CBSQ;Ryan et al., 2018), anddistress
using the Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983). These
measures have been previously described in detail (Chilcot et al., 2016). These measures
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demonstrated acceptable to good psychometric properties (i.e., internal reliabilities
>0.70) within the current study.
Statistical analysis
Questionnaire scores were computed using proration to account for missing items within
scales (Graham, 2009). This is described inmore detail elsewhere (Picariello et al., 2018). In
most cases, single items of a scale were left unanswered with the proportion of item-level
missing data per variable without proration fluctuating between 6.3 and 14.9% at baseline,
3.4 and 7.6% at 12 months, 0 and 2.4% at 24 months, and 0 and 1.5% at 36 months. Given
the small volume of missing item data and no systematic patterns of missingness, it is
unlikely that multiple imputation at the item level would result in different findings
compared to proration, despite criticisms in relation to proration (Mazza et al., 2015).
Approximately 33.3 and 36.6% of observations were missing and not due to death or
transplantation in the fatigue severity and fatigue-related functional impairment models,
respectively. Based on descriptive statistics and tabulated patterns, data were unlikely to be
missing completely at random, particularly in the comparison of participants who died
versus thosewhowere transplanted. A survival analysis from this study cohort indicated that
fatigue severity and fatigue-related functional impairment were significantly associated with
an increased risk of death anddecreased likelihoodof transplantation (Picariello et al., 2018).
Nonetheless, Little’sMCAR test at each time-point indicated that thepatternofmissingvalues
did not depend on the data values (baseline v2(df = 275, N = 174) = 274.59, p = .51;
12 months v2(df = 178, N = 118) = 182.60, p = .39; 24 months v2(df = 46,
N = 84) = 49.60, p = .33; 36 months v2(df = 46, N = 66) = 47.79, p = .40). Therefore,
multiple imputation analyses were conducted, according to Sterne et al. (2009) using 20
imputations and including variables in the model associated with missingness, such as total
time in the study, and censoring indicators. Multiply imputed data were deleted for patients
after they had died or had a transplant; therefore, datawere only imputed for 23%of the total
sample. This dataset was used for the linear growth models.
Univariate associations between sociodemographic, clinical, and psychological
variables with fatigue severity and fatigue-related functional impairment were examined
using bivariate correlations (Pearson or Spearman depending on normal distribution of
the data) for continuous variables; ANOVA comparisons for normally distributed
categorical variables or the nonparametric Kruskal–Wallis H test. Gender, age,
haemoglobin, and dialysis vintage, referring to length of time on dialysis, were included
in allmodels, irrespective of their univariate associationswith fatigue outcomes. Although
significant correlations were evident between all psychological predictor variables and
fatigue outcomes, they were selected for inclusion in the models based on univariate
linear growth models.
Fatigue over time was modelled using mixed-effects regression models, which when
applied to longitudinal data are often referred to as linear growthmodels (Rabe-Hesketh&
Skrondal, 2008; StataCorp Longitudinal, 2005). Fatigue severity and fatigue-related
functional impairment were used as continuous outcome variables in the models. These
models are a generalization of the standard linear regression model that allow the analysis
of repeated measures through the inclusion of random effects, which are estimates of the
between-person variability. In the analyses presented here,we allowed for both a random
intercept, capturing variability in the initial level of fatigue, and a random slope for the
time variable, capturing variability in the rate of change in fatigue. Here, timewas coded as
months from the baseline assessment. Non-linear functions of time were assessed;
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however, standard criteria (chi-square and fit indices) indicated a linear rate of change as
providing the most parsimonious fit to the data. The association between hypothesized
predictors with the initial level of fatigue and the rate of change in fatigue was assessed by
including a predictor variable and a predictor by time interaction term in the model.
Between-person and within-person variability was considered as part of exploratory
data analysis, including an exploration of any time-dependent effects of age and dialysis
vintage based on themixed evidenceon the association of these constructswith fatigue in
this patient population. Exploratory analysis indicated that both fatigue severity and
fatigue-related functional impairment varied non-linearly by dialysis vintage. The
identified pattern in fatigue severity also makes sense physiologically, as well as
psychologically, as patients in pre-dialysis care have an accumulation of fluid and toxins in
their bodies, which improves with initiation of dialysis, but over time, the physiological
consequences of dialysis and treatment burden may contribute to the increase in fatigue.
Therefore, an alternative parameterization of time to the one above was implemented
where time was coded as months from dialysis initiation, rather than time from baseline
assessment. A piecewise linear growth model was estimated. This model extends the
model described above to allow for different phases of change by the inclusion of more
than one random time slope (Bryk & Raudenbush, 1992; Van Der Leeden, 1998).
Specifically, we included two linear time slopes with a change point at 24 months
allowing for the estimation of the initial level of fatigue, the rate of change in fatigue
between 0 and 24 months from dialysis initiation, and the rate of change after 24 months
fromdialysis initiation. Predictors of fatigue outcomeswere examinedusing linear growth
models described earlier because more than half of the sample was receiving dialysis for
24 months or longer at baseline (N = 101, 58%).
Descriptive statistics and exploratory statistics were conducted in SPSS version 24.
Models looking at fatigue over time and predictors of fatigue outcomeswere conducted in
STATA version 15. Data were converted from wide to long format and set as longitudinal
(xtset) (Torres-Reyna, 2007) to use themixed command formultilevelmixed-effects linear
regressions (Box 1; Rabe-Hesketh & Skrondal, 2008; StataCorp Longitudinal, 2005). To
apply the piecewisemodel, dialysis vintagewas recoded to fit linearmodels in eachperiod
(Bryk & Raudenbush, 1992), where at each follow-up for slope 1 dialysis vintage of over
24 monthswas capped at 24,whereas for slope 2, dialysis vintage of 24 months or shorter
was recoded as 0. Significance was set at p ≤ .05, using the standard a cut-off.
Results
Sample characteristics
Baseline sociodemographic and clinical characteristics have been previously described
elsewhere (Chilcot et al., 2016) and are available in Table 1. Most of the sample was male
Box 1. STATA commands used
Piecewise growth model command
mi estimate: mixed CFQ/WSAS dialysisvintage_1_ dialysisvintage_2_ || id:
Linear growth model using follow-up time with predictors command
mi estimate: mixed CFQ/WSAS(c.time)##(list of predictors) || id:
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Table 1. Sociodemographic, clinical, and biochemical characteristics of the sample at baseline (n = 174)
Variable Statistic
Sociodemographic characteristics
Female (N, %) 64 (36.8%)
Age (M, SD, range) 59 (SD = 15.17); range = 25–92
BMI (M, SD, range) 28.33 (SD = 6.21); range = 17.40–
49.80
Ethnicity (N, %)
Caucasian 75 (43.1%)
Black 81 (46.6%)
Asian 15 (8.6%)
Marital status (N, %)
Married/living with partner 78 (44.8%)
Divorced/separated/never married/single/single parent 72 (41.4%)
Living with partner, friends, relatives 94 (54.0%)
Living alone 48 (27.6%)
Employment status (N, %)
Working full-time/working part-time/housekeeping/
self-employed
29 (16.7%)
Retired 59 (33.9%)
Unemployed 14 (8.0%)
None of the above 7 (4.0%)
Smoking status (N, %)
Smoker 18 (10.3%)
Ex-smoker 45 (25.9%)
Non-smoker 111 (63.8%)
Exercise status (N, %)
More than three times per week 44 (25.3%)
Less than three times per week 51 (29.3%)
Not at all 79 (45.4%)
Clinical characteristics
Transplant status (N, %)
Active 33 (19.0%)
Unfit but to reconsider/suspended/being worked up for
transplant
75 (43.1%)
Unfit/ unfit permanently/patient requested 65 (37.4%)
Primary renal diagnosis (N, %)
Type 2 diabetes related 45 (25.9%)
Hypertensive renal failure 41 (23.6%)
Access type (N, %)
Haemocath 47 (27.0%)
Brachial fistula 83 (47.7%)
Radial fistula 35 (20.1%)
Arm 9 (5.2%)
Dialysis vintage in months (median, interquartile range, range) 35 (interquartile range = 52);
range = 3–304
ESA (N, %)
Yes 141 (81%)
No 9 (5.2%)
I don’t know 21 (12.1%)
Continued
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(63.2%) with a mean age of 59 years old (SD = 15.17). The median dialysis vintage (time
on dialysis) was 35 months (interquartile range: 52). A bar chart summarizing the
frequency distribution of dialysis vintage at baseline in this sample can be found in the
Supplementary File S1. At baseline, mean fatigue was 17.34 (SD = 6.54) and 82 patients
(47.1%) scored above the threshold for clinical fatigue, scoring 18 or above on the CFQ.
Fatigue severity ranged from 16.49 (SD = 6.12 at 36 months) to 18.26 (SD = 6.27 at
24 months) across follow-up time-points. At baseline, the mean fatigue-related functional
impairment score was 18.5 (SD = 13.00), reaching a maximum of 22.37 (SD = 11.44) at
24 months. Descriptive fatigue data over time are presented in Table 2.
Just over half of the participants who were fatigued at baseline remained fatigued at
12 months and slightly less than a quarter of participants remained fatigued by
36 months. Around 9 to 14% of participants who were not fatigued at baseline became
fatigued at follow-up.
Psychological variables over time
Table 2 displays the descriptive characteristics of the psychological variables at each time-
point, based on the observed data. According to linear growth models, the yearly change
in fatigue severitywas0.15 (p = .46, 95%CI0.56 to 0.25),while therewas a significant
increase in fatigue-related functional impairment of 1.17 each year (p = .002, 95% CI 0.42
to 1.92). Using the MI dataset, the yearly change in fatigue severity was 0.11 (p = .68,
95% CI 0.63 to 0.41) and in fatigue-related functional impairment was 1.40 (p = .010,
95%CI 0.33 to2.46). Similarly, relyingonly onparticipantswhocompleted each follow-up
(N = 66), the yearly change in fatigue severity was0.24 (p = .31, 95% CI0.71 to 0.23)
and in fatigue-related functional impairment was 0.91 (p = .037, 95% CI 0.06 to 1.75).
Using theMI dataset, without participants who died or were transplanted over the course
of the study; produced similar results, with a yearly change in fatigue severity of 0.13
(p = .68, 95% CI 0.75 to 0.49) and in fatigue-related functional impairment of 1.39
(p = .041, 95% CI 0.06 to 2.73). Therefore, the findings are generally congruent.
Table 1. (Continued)
Variable Statistic
Charlson Comorbidity Score (M, SD, range) 3.85 (SD = 1.93); range = 2–9
Biochemical characteristics
Haemoglobin (g/L) (M, SD, range) 109.56 (SD = 11.09); range = 62–
140
Albumin (g/L) (M, SD, range) 39.33 (SD = 3.96); range = 22–55
Creatinine (µmol/L) (M, SD, range) 809.53 (SD = 292.34); range = 182–
1,567
Urea (mmol/L) (M, SD, range) 20.10 (SD = 6.95); range = 4–57
IDWL (kg) (M, SD, range) 1.91 (SD = 1.01); range = 6.40
to 0.10
URR (%) (M, SD, range) 67.61 (SD = 6.93); range = 31–91
CRP (mg/L) (median, interquartile range, range) 11.50 (interquartile range = 20.90);
range = 1–216
Notes. BMI = body mass index; ESA = erythropoietin-stimulating agents; IDWL = intradialytic weight
loss (weight lost during a dialysis session); URR = urea reduction ratio (marker of dialysis adequacy);
CRP = C-reactive protein (marker of inflammation).
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Fatigue over time in HD 11
Based on unadjusted linear growth models, there were no significant changes over
time in any of the psychological predictor variables, except for distress (Table 2). The
yearly reduction in distress was 0.46 (p = .038, 95% CI 0.90 to 0.03).
Predictors of fatigue severity over time
The results for each step of themodel are available in Table 3. In the final model, including
all the predictor variables (N = 14), only ethnicity was a significant predictor of the initial
level of fatigue severity (B = 2.95, p = .024, 95% CI 5.51 to 0.40) and change in
fatigue severity (B = 1.36, p = .009, 95% CI 0.35 to 2.36). Non-white ethnicity was
associated with a 2.95 lower initial fatigue severity and a reduction in fatigue severity of
1.60 points each year. These coefficients represent clinically significant changes in fatigue
severity on the CFQ, particularly taking into consideration the additive impact of ethnicity
over time (Nordin et al., 2016). In addition, a one-point increase in haemoglobin was
predictive of a small, but not clinicallymeaningful (Nordin et al., 2016), increase in fatigue
severity of .02 each year (B = 0.05, p = .050, 95% CI 0.10, 0.00008).
Engaging in exercise at baseline was a significant predictor of lower initial fatigue
severity, until distress was added to the model. Similarly, exercise status at baseline was
predictive of a reduction in fatigue severity of 1.98 (step 1) and 2.13 (step 2) each year,
respectively, until distress was added to the model. Distress was a significant predictor of
the initial level of fatigue severity, where a one-point increase in distress was associated
with a 0.30 increase in initial fatigue severity. This association ceased to be significant after
negative beliefs about fatigue were added to the model. Lastly, a one-point increase in
comorbidities (CCI) was associated with a 0.59 higher initial level of fatigue severity, but
this was only marginally significant (95% CI 0.003, 1.18; step 2).
Predictors of fatigue-related functional impairment over time
The results for each step of themodel are available in Table 4. In the final model, including
all the predictor variables (N = 15), no significant predictors of the initial level of fatigue-
related functional impairment could be identified. On the contrary, change in fatigue-
related functional impairment was significantly associated with damage beliefs, after
controlling for sociodemographic, clinical, and other psychological variables (B = 0.31,
p = .041, 95% CI0.61 to0.01). A one-point increase in damage beliefs was associated
with a 0.36 increase in fatigue-related functional each year. This is unlikely to be a
clinically significant change in fatigue-related functional impairment (Zahra et al., 2014);
however, over 3 years this would amount to an increase of 1.08 in fatigue-related
functional impairment, where following therapy the mean change in WSAS has been
reported to be 5.07 (Zahra et al., 2014).
Higher BMI at baseline was a significant predictor of greater initial fatigue-related
functional impairment (step 1), yet ceased to be significant when clinical factors were
added to the model. Being employed and engaging in exercise at baseline, on the other
hand, were significant predictors of lower initial fatigue-related functional impairment.
However, employment status was only marginally significant after distress was added to
the model, while exercise status remained a significant predictor of initial fatigue-related
functional impairment until negative beliefs about fatigue were added to the model.
Additionally, in steps 1 and 2, engaging in exercise at baseline was predictive of a
reduction in fatigue-related functional impairment by 1.19 each year, until distress was
added to the model.
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Being deemed unfit for a transplant at baseline was also predictive of greater initial
fatigue-related functional impairment in step 2, but this association was only
marginally significant (95% CI 0.09 to 10.31). Lastly, a one-point increase in distress
was associated with a 0.69 increase in initial fatigue-related functional impairment, but
this association ceased to be significant after negative beliefs about fatigue were added
to the model.
The predictors of fatigue severity and fatigue-related functional impairment were
generally consistent when including only participants who self-identified as White,
Black African, Black Caribbean, or Black Other (N = 156; please see Supplementary
File S4).
Fatigue piecewise growth models
According to apiecewise growthmodel based on the observed data, in the first 24 months
fromdialysis initiation, therewas a significant reduction in fatigue severity (beta = 0.15,
p = .007, 95% CI 0.25 to 0.04); however, with a longer dialysis vintage (over
24 months), a small increase in fatigue severity, approaching significance, could be
observed (beta = 0.01, p = .070, 95% CI 0.001 to 0.03; Supplementary File S2). In
contrast, fatigue-related functional impairment appeared relatively stable across dialysis
vintage. In the first 24 months of dialysis vintage, there was a non-significant increase in
fatigue-related functional impairment (beta = 0.17, p = .09, 95% CI 0.03 to 0.37), yet
with a longer dialysis vintage (over 24 months), this increase flattened (beta = 0.01,
p = .53, 95% CI 0.02 to 0.04; Supplementary File S3).
Discussion
The aim of this paperwas to assess the trajectories of fatigue outcomes over 3 years and to
identify predictors of these among prevalent (those receiving dialysis for 3 months or
longer) in-centre HD patients.
Similar to previous estimates of the prevalence of fatigue among dialysis patients
(Almutary et al., 2013),we found that approximately one in two patients (47.1%) could be
deemed clinically fatigued at baseline, and many of those fatigued at baseline, who were
followed up, remained fatigued at each subsequent follow-up.
The findings of the piecewise and linear growth models complement each other and
reveal important nuances regarding fatigue change, suggesting that fatigue severity does
not follow one linear trend of reduction over time. Fatigue severity appears to decrease
within the first 24 months of dialysis, increasing thereafter with dialysis vintage.
While strong associations were evident across follow-ups between all psychological
predictors and fatigue outcomes, this was not reflected in the linear growth models,
which is also in contrast to the cross-sectional findings of this study (Chilcot et al., 2016).
Psychological factors did not appear to play a significant role in fatigue severity, after
controlling for sociodemographic and clinical factors. A lower initial level of fatigue
severity and a reduction in fatigue severity each year were predicted by non-White
ethnicity here. Contrary to expectations, an increase in haemoglobin was significantly
associated with a small increase in fatigue severity each year. It is important to note that
assessing the effects of time-dependent haemoglobin using a single measurement per
time-point is less precise, and a time-averaged haemoglobin estimate over 3 to 4 months
would be more appropriate.
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Similarly, none of the sociodemographic, clinical, nor psychological variables emerged
as significant predictors of the initial level of fatigue-related functional impairment.
Damage beliefs in response to fatigue were the only significant predictor of an increase in
fatigue-related functional impairment each year. The stepped approach adopted with the
linear models, revealed some other factors that may play a role in fatigue outcomes,
including employment status, exercise status, and distress. However, these factors were
attenuated by the addition of psychological predictors to the models, suggesting some
collinearity between the variables.
The findings of this studymake a valuable contribution to our understanding of fatigue
outcomes over time among dialysis patients, exceeding follow-up periods of previous
longitudinal studies in this setting (Bossola et al., 2017; Jhamb et al., 2009, 2011). An
important novel insight from this study is that fatigue is notmerely associatedwith dialysis
vintage, as previously suggested by some studies (Jhamb et al., 2011), but rather changes
over the course of dialysis vintage. In the longitudinal study of fatigue over 1 year among
prevalent HD patients by Bossola et al. (2017), fatigue severity also appeared relatively
stable and was generally unexplained by sociodemographic and clinical factors when
using the arbitrary follow-up time.
Contrary to expectations and previous findings on the important role beliefs and
behaviours play in illness and symptom experience, including fatigue, across different
LTCs (Hagger et al., 2017), only damage beliefs in response to fatigue independently
predicted greater fatigue-related functional impairment over time here. The role of
damage beliefs in fatigue-related functional impairment was also evident in the cross-
sectional data (Chilcot et al., 2016). Damage beliefs may be a proxy of actual damage
occurring to the body as perceivedby thepatient; however, in linewith existing literature,
the majority of clinical factors, such as Hb, albumin, dialysis adequacy (URR), did not
contribute significantly to fatigue severity and fatigue-related functional impairment here
and the association between damage beliefs and fatigue-related functional impairment
was above and beyond the role of clinical factors. Believing that fatigue is a sign of damage
appeared particularly salient to renal patients and has been previously reported in a
qualitative study, where patients often struggled to dissociate fatigue from the experience
of the illness and treatment (Picariello et al., 2017a, 2017). Higher levels of damage beliefs,
alongside catastrophizing and symptom focusing, were also observed in a sample of
fatigued RA patients, possibly maintaining and perpetuating fatigue for this group as well
(Ali et al., 2017).
In line with previous findings, non-White patients experience lower fatigue and are
less likely to experience an increase in fatigue over time in this patient population (Jhamb
et al., 2009, 2011;Kutner&Devins, 1998; Kutner et al., 2000, 2005), possibly as a result of
cultural differences in perception of the illness and treatment (Unruh et al., 2004),
variations in coping styles employed (Bhui et al., 2011; Prelow et al., 2000; Triandis et al.,
1984), or due to stigma associated with disclosing distress and maladjustment (Cooper-
Patrick et al., 1997; de Crane & Spielberger, 1981; Thompson et al., 2004). Education and
health literacy are also likely to be important confounders here. Lower educational
attainment and lowhealth literacymay influence fatigue via a poorer understanding of the
illness and non-adherence, while patients with greater educational attainment may be
more aware of the gravity and consequences of the illness. This further accentuates the
complex aetiology of fatigue. It is also essential to consider this finding alongside the
epidemiology of chronic kidney disease (CKD). The median age of patients on dialysis is
highly dependent on ethnicity, specifically non-White patients tend to be younger (Hole
et al., 2018; MacNeill et al., 2018). Therefore, age is also a likely explanation here. It is also
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yet to be determined whether the self-report instruments used here are cross-culturally
valid.
According to the findings here, the timing of intervention deliverymay be of relevance
for patients on dialysis, as 24 months from dialysis initiation marked a change in the
trajectory of fatigue severity. There is accumulating evidence in support of psychological
interventions, such as cognitive-behavioural therapy for the management of fatigue in
physical LTCs (van denAkker et al., 2016) and promising preliminary evidence is available
in kidney failure (Picariello et al., 2017). However, what modifiable cognitive and
behavioural factors are associatedwith fatigue trajectories over the spanof dialysis vintage
is yet to be defined.
To our knowledge, this is the first study to assess the contribution of fatigue-specific
cognitive and behavioural factors to fatigue among in-centre HD patients. An additional
strength of the study is its longitudinal design, enabling us to evaluate the trajectories of
fatigue severity and fatigue-related functional impairment over 3 years and identify factors
that may predict changes in fatigue, in an area that is largely dominated by cross-sectional
research.
However, the current study has several important limitations. Firstly, although the
sample consisted of 174 patients at baseline, it is still limited in size, particularly given the
longitudinal study design, restricting the complexity of the analysis that could be
conducted. In the light of findings in other LTCs, it would be clinically valuable to explore
whether different clusters of fatigue trajectories exist in this patient population, using
latent class growthmodelling (Jung &Wickrama, 2008; Nagin &Odgers, 2010). Although
high levels of attrition are inevitable in this patient population, the findings need to be
interpreted with caution.
While the longitudinal design played a critical role in determining that fatigue changes
with dialysis vintage, as prevalent HD patients were recruited into the study, this
considerably limited our ability to use the natural trajectory of fatigue based on dialysis
vintage to identify predictors of fatigue. Future studies should assess predictors of fatigue
outcomes longitudinally using a larger sample of incident dialysis patients, those new to
dialysis. However, such a study may prove challenging to conduct in practice, as the
number of patients starting HD at any one centre per year is limited (Hole et al., 2018).
Fatigue is also common in CKD patients who do not require RRT (Abdel-Kader et al.,
2009); therefore, dialysis initiation may not necessarily reflect symptom onset.
Despite the longitudinal study design, predictor and outcomes variables captured
individuals’ internal states simultaneously, consequently reciprocal causation remains a
problem (Singer &Willett, 2003). To circumvent this, asymptomatic CKD patients could
be recruited and followed up beyond dialysis initiation; however, unless in the context of
a large prospective epidemiological study, this is unlikely to be feasible in practice.
Although collecting data on-dialysis provided consistency and minimized patient
burden, there is evidence of significant fluctuations in fatigue as a consequence of dialysis
(Brys et al., 2019); therefore, to capture the full complexity of fatigue in this patient
population, combining average and momentary assessments would be essential and
would enable the identification of fatigue predictors both at the group level and at the
individual level. Within-person methodology can also help to circumvent the limited
target population of incident dialysis patients.
Due to concerns about patient burden, the role of important factors like subjective
sleep quality, social support, and representation of the illness was not assessed here.
Additionally, the use of the total BIPQ score precluded us here from exploring the role of
individual fatigue perceptions.
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Additional limitations, including the possibility of non-response bias, generalizability
of findings to non-English-speaking samples, and sporadic availability of CRP from clinical
records, have been previously addressed elsewhere (Chilcot et al., 2016; Picariello et al.,
2018).
Conclusion
In conclusion, changes in fatigue outcomes over time may be more complex than
originally anticipated, varying by the length of time on dialysis, as the data suggested here.
This provides some indication of when treatment for fatigue may be effectively delivered,
yet the targets of treatment need to be explored further using a sample of incident dialysis
patients.
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